Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-25 @ 3:52 AM
NCT ID:
NCT06955702
Eligibility Criteria:
Inclusion Criteria:
* Female participants aged ≥18 years
* Newly diagnosed breast cancer (any stage)
* Scheduled to receive anthracycline- and/or taxane-based chemotherapy as first-line systemic treatment
* No prior history of antineoplastic treatment
* Willing and able to provide written informed consent
Exclusion Criteria:
* Patients with recurrent disease who have received prior hormone therapy, chemotherapy, and/or immunotherapy
* Presence of alopecia prior to the initiation of cancer treatment
* History of cerebral radiotherapy
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06955702
Study Brief:
Protocol Section:
NCT06955702